Desmoplastic melanoma: Is there a role for sentinel lymph node biopsy?

Annals of Surgical Oncology

Volumn 20, Issue 7, 2013, Pages 2345-2351

  Han, Dale ^a   Zager, Jonathan S ^a,b   Yu, Daohai ^a   Zhao, Xiuhua ^a   Walls, Brooke ^a   Marzban, Suroosh S ^a   Rao, Nikhil G ^a   Sondak, Vernon K ^a,b   Messina, Jane L ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; PROTEIN S 100;

ADULT; AGED; CANCER RECURRENCE; CAUSE OF DEATH; DEATH; DEMOGRAPHY; DESMOPLASTIC MELANOMA; FEMALE; FISHERMAN; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; STAINING;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84878822033     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2883-z     Document Type: Review

References (38)

1. Quinn MJ, Crotty KA, Thompson JF, Coates AS, O'Brien CJ, McCarthy WH. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer. 1998;83:1128-35. (Pubitemid 28419065)
2. Busam KJ. Cutaneous desmoplastic melanoma. Adv Anat Pathol. 2005;12:92-102. (Pubitemid 40515797)
3. Feng Z, Wu X, Chen V, Velie E, Zhang Z. Incidence and survival of desmoplastic melanoma in the United States, 1992-2007. J Cutan Pathol. 2011;38:616-24.
4. Busam KJ, Mujumdar U, Hummer AJ, Nobrega J, Hawkins WG, Coit DG, et al. Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol. 2004;28:1518-25. (Pubitemid 39425520)
5. Jaroszewski DE, Pockaj BA, DiCaudo DJ, Bite U. The clinical behavior of desmoplastic melanoma. Am J Surg. 2001;182:590-5. (Pubitemid 34142677)
6. Livestro DP, Muzikansky A, Kaine EM, Flotte TJ, Sober AJ, Mihm MC Jr, et al. Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol. 2005;23:6739-46. (Pubitemid 46190269)
7. Hawkins WG, Busam KJ, Ben-Porat L, Panageas KS, Coit DG, Gyorki DE, et al. Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Ann Surg Oncol. 2005;12:207-13. (Pubitemid 40568907)
8. Pawlik TM, Ross MI, Prieto VG, Ballo MT, Johnson MM, Mansfield PF, et al. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer. 2006;106:900-6. (Pubitemid 43238458)
9. Davison JM, Rosenbaum E, Barrett TL, Goldenberg D, Hoque MO, Sidransky D, et al. Absence of V599E BRAF mutations in desmoplastic melanomas. Cancer. 2005;103:788-92. (Pubitemid 40216408)
10. Su LD, Fullen DR, Lowe L, Wang TS, Schwartz JL, Cimmino VM, et al. Desmoplastic and neurotropic melanoma. Cancer. 2004;100:598-604. (Pubitemid 38124779)
11. Posther KE, Selim MA, Mosca PJ, Stanley WE, Johnson JL, Tyler DS, et al. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma. Ann Surg Oncol. 2006;13:728-39.
12. Gyorki DE, Busam K, Panageas K, Brady MS, Coit DG. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol. 2003;10:403-7. (Pubitemid 40486938)
13. Wasif N, Gray RJ, Pockaj BA. Desmoplastic melanoma - the step-child in the melanoma family? J Surg Oncol. 2011;103:158-62.
14. Thelmo MC, Sagebiel RW, Treseler PA, Morita ET, Nguyen LH, Kashani-Sabet M, et al. Evaluation of sentinel lymph node status in spindle cell melanomas. J Am Acad Dermatol. 2001;44:451-5. (Pubitemid 32199964)
15. Murali R, Shaw HM, Lai K, McCarthy SW, Quinn MJ, Stretch JR, et al. Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients. Cancer. 2010;116:4130-8.
16. Mohebati A, Ganly I, Busam KJ, Coit D, Kraus DH, Shah JP, et al. The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma. Ann Surg Oncol. 2012;19:4307-13.
17. George E, McClain SE, Slingluff CL, Polissar NL, Patterson JW. Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis. J Cutan Pathol. 2009;36:425-32.
18. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Melanoma, version 1.2013. National Comprehensive Cancer Network, Fort Washington, PA. Available at: www.NCCN.org, 2013.
19. Wong SL, Balch CM, Hurley P, Agarwala SS, Akhurst TJ, Cochran A, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline. Ann Surg Oncol. 2012;19:3313-24.
20. Wong SL, Balch CM, Hurley P, Agarwala SS, Akhurst TJ, Cochran A, et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline. J Clin Oncol. 2012;30:2912-8.
21. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-9.
22. Ross MI, Reintgen D, Balch CM. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol. 1993;9:219-23. (Pubitemid 23154458)
23. Carlson JA, Dickersin GR, Sober AJ, Barnhill RL. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer. 1995;75:478-94.
24. Payne WG, Kearney R, Wells K, Blue M, Walusimbi M, Mosiello G, et al. Desmoplastic melanoma. Am Surg. 2001;67:1004-6. (Pubitemid 33738135)
25. Smithers BM, McLeod GR, Little JH. Desmoplastic melanoma: patterns of recurrence. World J Surg. 1992;16:186-90.
26. Gershenwald JE, Mansfield PF, Lee JE, Ross MI. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or =4 mm) primary melanoma. Ann Surg Oncol. 2000;7:160-5. (Pubitemid 30164687)
27. Scoggins CR, Bowen AL, Martin RC, 2nd, Edwards MJ, Reintgen DS, Ross MI, et al. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma. Arch Surg. 2010;145:622-7.
28. Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, et al. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. J Am Acad Dermatol. 2001;44:762-6. (Pubitemid 32391162)
29. Gajdos C, Griffith KA, Wong SL, Johnson TM, Chang AE, Cimmino VM, et al. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer. 2009;115:5752-60.
30. Murali R, Zannino D, Synnott M, McCarthy SW, Thompson JF, Scolyer RA. Clinical and pathological features of metastases of primary cutaneous desmoplastic melanoma. Histopathology. 2011;58:886-95.
31. Scoggins CR, Martin RC, Ross MI, Edwards MJ, Reintgen DS, Urist MM, et al. Factors associated with false-negative sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol. 2010;17:709-17.
32. Tanis PJ, Nieweg OE, van den Brekel MW, Balm AJ. Dilemma of clinically node-negative head and neck melanoma: outcome of "watch and wait" policy, elective lymph node dissection, and sentinel node biopsy - a systematic review. Head Neck. 2008;30:380-9. (Pubitemid 351480755)
33. Martin RC, Shannon KF, Quinn MJ, Saw RP, Spillane AJ, Stretch JR, et al. The management of cervical lymph nodes in patients with cutaneous melanoma. Ann Surg Oncol. 2012;19:3926-32.
34. Erman AB, Collar RM, Griffith KA, Lowe L, Sabel MS, Bichakjian CK, et al. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer. 2012;118:1040-7.
35. Parrett BM, Kashani-Sabet M, Singer MI, Li R, Thummala S, Fadaki N, et al. Long-term prognosis and significance of the sentinel lymph node in head and neck melanoma. Otolaryngol Head Neck Surg. 2012;147:699-706.
36. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-17. (Pubitemid 44465459)
37. Wrightson WR, Wong SL, Edwards MJ, Chao C, Reintgen DS, Ross MI, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol. 2003;10:676-80. (Pubitemid 40486900)
38. Morton DL, Cochran AJ, Thompson JF. The rationale for sentinel-node biopsy in primary melanoma. Nat Clin Pract Oncol. 2008;5:510-1.